Tuesday, December 06, 2016 6:29:11 PM
- interim event / announcement (start of the process, was March 31, 2016 @ 1st) - mmm.dd (d1)
- interim announcement (was September 12, 2016 @ 1st) - mmm.dd (d2)
- outcome - stop (as it is) or cont. (as it is) or futility
- Eff% - xx.xx%
Rules (if you have different proposal, please advise):
* weight:
- interim event - 30% (w1)
- interim announcement (DMC recommendation) - 30% (w2)
- Eff% - 35% (w3)
(if interim event date won't be available: 50-50%)
* difference:
- D1: ABS (real interim event - d1)
- D2: ABS (real interim announcement (DMC recommendation) - d2)
* D3: difference in percentage 2 digits, eg. 1.15% diff = 115 score (Eff% - d2)
* d1 x w1+ d2 x w2 +d3 x w3 = score
* lowest score will win
"Sub-rules" (if you have different proposal, please advise):
- no data = the highest score in the category + 10%
Feel free to correct or join till (the earlier of) December 31, 2016 or update from Amarin.
(Don't have to guess all, but please keep the order. ie.: March 31 / Sept 12 / 25%
Please note:
- I will change the date to the next working day if a guess is Saturday, Sunday or (US) Holiday
- If no exact date, I used the middle of te period
...............................................................................................................................................................................
ziploc_1: stop / Feb. 01. / May. 01. / 35.00%
mrmainstreet: cont. / Feb. 01. / Jul. 03. / na
CaptBeer: cont. / Feb. 02. / Jun. 19. / na
KChung: stop / Feb. 23. / Jun. 12. / 34.00%
zumantu: stop / Feb. 23. / Jun. 22. / 30.50%
marzan: stop / Feb. 24. / May. 24. / 53.00%
HDGabor: stop / Feb 24. (10-K CC) / Jun 12. / 36.00%
drrc1949: stop / Feb. 27. / Aug. 09. / 35.00%
Biofalcon: cont. / Mar. 06. / Jul. 20. / 23.00%*
rafunrafun: cont. / Mar. 13. / Jul. 17. / 33.00%*
invest2992: stop / Mar. 14. / Jul. 10. / 33.33%
Biobillionair: stop / Mar. 14. / Aug. 14. / 45.00%
tasgrewaf: stop / Mar. 15. / Jun. 15. / 23.45%
irc203: stop / Mar. 17. / Jul. 25. / 27.00%
slowmover: stop / Mar. 20. / Jun. 28. / 22.50%
lbwagain: stop / Mar. 20. / Jul. 12. / 33.00%
VuBru: stop / Mar. 21. / Jun. 20. / 19.50%
Hspooner: stop / Mar. 24. / Jun. 23. / 31.00%
ibew 488: stop / Mar. 24. / Jul. 27. / 35.00%
Mochachip: stop / Mar. 31. / Jul. 31. / na
oneragman: stop / Mar. 31. / Aug. 07. / 31.00%
Pharmacydude: stop / Apr. 03. / Sep. 05. / 25.00%
Nukemtiltheyglow: stop / Apr. 04. / Jun. 23. / 25.00%
Whalatane: stop / Apr. 14. / Jul. 31. / 19.00%
Hondo1021: stop / Apr. 20. / Jun. 23. / 28.00%
annac: stop /Apr. 22. / Jul. 24. / 20,00%
heysfguy: stop / Apr. 24. / Jul. 24. / 22.00%
* in case of cont. RRR projection is interesting ...
...............................................................................................................................................................................
Participated in #1, but did not submit a guess for #2:
acuzuss:
Albino2:
alwayswatching1:
Benny7459:
BioChica:
chas1232123:
Danouse:
FishyFingers:
goamrn:
golf stud
gozips:
Invest83838:
isaeed:
James364202:
Louieblouie:
Mogwai:
PghKid1 (from ST)
Repero:
rosemountbomber:
rydad21:
Sam81:
Squeck:
xblkbk:
...............................................................................................................................................................................
Best,
G
#STRONGERTOGETHER
Disclosure: I am long with this stock. I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for it.
Recent AMRN News
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/04/2024 10:30:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 01:00:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 12:06:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:05:56 PM
- Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024 • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/12/2024 01:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:31:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 12:00:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 09:31:21 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM